- Home
- PAVS vs QNCX Comparison
PAVS vs QNCX Comparison
Compare PAVS & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- QNCX
- Stock Information
- Founded
- PAVS 2004
- QNCX 2012
- Country
- PAVS United States
- QNCX United States
- Employees
- PAVS N/A
- QNCX N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAVS Health Care
- QNCX Health Care
- Exchange
- PAVS Nasdaq
- QNCX Nasdaq
- Market Cap
- PAVS 49.1M
- QNCX 85.9M
- IPO Year
- PAVS 2019
- QNCX 2019
- Fundamental
- Price
- PAVS $0.78
- QNCX $1.65
- Analyst Decision
- PAVS
- QNCX Strong Buy
- Analyst Count
- PAVS 0
- QNCX 6
- Target Price
- PAVS N/A
- QNCX $8.00
- AVG Volume (30 Days)
- PAVS 147.1K
- QNCX 118.4K
- Earning Date
- PAVS 08-04-2025
- QNCX 11-12-2025
- Dividend Yield
- PAVS N/A
- QNCX N/A
- EPS Growth
- PAVS N/A
- QNCX N/A
- EPS
- PAVS N/A
- QNCX N/A
- Revenue
- PAVS $71,542.00
- QNCX N/A
- Revenue This Year
- PAVS N/A
- QNCX N/A
- Revenue Next Year
- PAVS N/A
- QNCX N/A
- P/E Ratio
- PAVS N/A
- QNCX N/A
- Revenue Growth
- PAVS N/A
- QNCX N/A
- 52 Week Low
- PAVS $0.32
- QNCX $0.69
- 52 Week High
- PAVS $1.50
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- PAVS 48.43
- QNCX 53.76
- Support Level
- PAVS $0.76
- QNCX $1.56
- Resistance Level
- PAVS $0.90
- QNCX $1.65
- Average True Range (ATR)
- PAVS 0.11
- QNCX 0.07
- MACD
- PAVS 0.01
- QNCX -0.08
- Stochastic Oscillator
- PAVS 26.14
- QNCX 98.80
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.